Prosecution Insights
Prosecution Insights
19 pending office actions • 16 clients • 19 examiners • 17 art units • 0 of 19 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (5%) |
| §103 only | 10 (53%) |
| §102 only | 2 (11%) |
| §112 only | 1 (5%) |
| No statute on record | 5 (26%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FISCHER, JUSTIN R | 1 | 44.4% | +2.3% |
| VERKHOVSKY, VANI GUJULUVA | 1 | — | — |
| KOLOSOWSKI-GAGER, KATHERINE | 1 | 26.5% | +32.5% |
| KIM, DANIELLE A | 1 | 37.2% | +58.0% |
| METCALF, MATTHEW CURRAN | 1 | 100.0% | +0.0% |
| BECKHARDT, LYNDSEY MARIE | 1 | 28.2% | +48.7% |
| BOLDEN, ELIZABETH A | 1 | 85.2% | +22.2% |
| ROGERS, JAMES WILLIAM | 1 | 46.3% | +21.8% |
| SHAMEEM, GOLAM M | 1 | 86.9% | +16.0% |
| WITHERSPOON, SIKARL A | 1 | 86.1% | -20.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17780083 | Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor | SHAMEEM, GOLAM M | 87d overdue |
| 18311409 | MURINE ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR FOR TREATING CANCER | METCALF, MATTHEW CURRAN | 30d overdue |
| 18154917 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | WITHERSPOON, SIKARL A | 15d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251010 | FREEZE-DRIED COLLAGEN-SPONGE-TYPE COMPOSITION FOR BONE REGENERATION | BECKHARDT, LYNDSEY MARIE | 111d overdue |
| 18337225 | METHOD FOR ASSESSING FASTING STATUS AND FASTING STATUS ASSESSING SYSTEM | KOLOSOWSKI-GAGER, KATHERINE | 51d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251010 | FREEZE-DRIED COLLAGEN-SPONGE-TYPE COMPOSITION FOR BONE REGENERATION | BECKHARDT, LYNDSEY MARIE | 111d overdue |
| 17780083 | Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor | SHAMEEM, GOLAM M | 87d overdue |
| 18337225 | METHOD FOR ASSESSING FASTING STATUS AND FASTING STATUS ASSESSING SYSTEM | KOLOSOWSKI-GAGER, KATHERINE | 51d overdue |
| 18247303 | THERMAL INSULATION | BOLDEN, ELIZABETH A | 15d |
| 18119348 | BIOSENSING COMPOSITION HAVING SENSING GLUCOSE CONTENT, CONTACT LENS AND METHOD OF PREPARATION THEREOF | ROGERS, JAMES WILLIAM | 33d |
| 18209195 | AMINO ALCOHOL IONIZABLE LIPIDS | KIM, DANIELLE A | 34d |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| 1618 | 2 |
| 1749 | 1 |
| 1655 | 1 |
| 3687 | 1 |
| 1647 | 1 |
| 1731 | 1 |
| 1621 | 1 |
| 1692 | 1 |
| 1631 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18848318 | RUBBER COMPOSITION FOR AN INNER LINER FOR PNEUMATIC VEHICLE TIRES | Suncoal Industries GmbH | FISCHER, JUSTIN R | 1749 | §103 | Non-Final OA | 8d overdue | Pending | Sep 18, 2024 |
| 18350278 | NUTRITIONAL COMPOSITION FOR INHIBITING SURVIVAL OF RNA VIRUS AND METHOD FOR TREATING RNA VIRUS INFECTION | Trade Wind Biotech Co., Ltd. | VERKHOVSKY, VANI GUJULUVA | 1655 | §103 | Non-Final OA | 146d overdue | Pending | Jul 11, 2023 |
| 18337225 | METHOD FOR ASSESSING FASTING STATUS AND FASTING STATUS ASSESSING SYSTEM | China Medical University | KOLOSOWSKI-GAGER, KATHERINE | 3687 | §101 | Non-Final OA | 51d overdue | Pending | Jun 19, 2023 |
| 18209195 | AMINO ALCOHOL IONIZABLE LIPIDS | New Jersey Institute Of Technology | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | 34d | Pending | Jun 13, 2023 |
| 18311409 | MURINE ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR FOR TREATING CANCER | Pell Bio-Med Technology Co., Ltd. | METCALF, MATTHEW CURRAN | 1647 | §102 | Non-Final OA | 30d overdue | Pending | May 03, 2023 |
| 18251010 | FREEZE-DRIED COLLAGEN-SPONGE-TYPE COMPOSITION FOR BONE REGENERATION | Denhouse Co.,Ltd | BECKHARDT, LYNDSEY MARIE | 1613 | Other | Non-Final OA | 111d overdue | Pending | Apr 28, 2023 |
| 18247303 | THERMAL INSULATION | Thermal Ceramics UK Limited | BOLDEN, ELIZABETH A | 1731 | Other | Non-Final OA | 15d | Pending | Mar 30, 2023 |
| 18119348 | BIOSENSING COMPOSITION HAVING SENSING GLUCOSE CONTENT, CONTACT LENS AND METHOD OF PREPARATION THEREOF | National Yang Ming Chiao Tung University | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | 33d | Pending | Mar 09, 2023 |
| 17780083 | Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor | Benobio Co., Ltd. | SHAMEEM, GOLAM M | 1621 | §102 | Non-Final OA | 87d overdue | Pending | Jan 27, 2023 |
| 18154917 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | Heron Neutron Medical Corp. | WITHERSPOON, SIKARL A | 1692 | §103 | Non-Final OA | 15d | Pending | Jan 16, 2023 |
| 18004975 | METHOD FOR TREATING ISCHEMIA CONDITION OF TISSUE | Woei-Cherng Shyu | BATES, KEENAN ALEXANDER | 1631 | Other | Final Rejection | 5d | Pending | Jan 10, 2023 |
| 17801057 | PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE AND SODIUM BICARBONATE HAVING EXCELLENT RELEASE PROPERTIES | Chong Kun Dang Pharmaceutical Corp. | WESTERBERG, NISSA M | 1618 | Other | Final Rejection | 79d overdue | Pending | Aug 19, 2022 |
| 17850165 | METHOD FOR ASSESSING DRUG-RESISTANT MICROORGANISM AND DRUG-RESISTANT MICROORGANISM ASSESSING SYSTEM | China Medical University | OLJUSKIN, TIMUR YURYEVICH | 1685 | §103 | Non-Final OA | 35d | Pending | Jun 27, 2022 |
| 17746112 | VACCINE AND METHOD FOR TREATING CANCER | China Medical University | HOPKINS, SAMANTHA LAKE | 1641 | §112 | Final Rejection | 22d | Pending | May 17, 2022 |
| 17740592 | Simplified Multi-Part Refueling Device | Tecflower AG | ONDRASIK, JOHN PAUL | 2859 | §103 | Non-Final OA | 25d overdue | Pending | May 10, 2022 |
| 17766675 | Composition, Comprising Rip Kinase Inhibitor, For Preventing Hair Loss Or Promoting Hair Regrowth | Epi Biotech Co., Ltd. | HAVLIN, ROBERT H | 1626 | §103 | Non-Final OA | 107d overdue | Pending | Apr 05, 2022 |
| 17640864 | Therapeutic Methods And Uses Thereof | Eustralis Pharmaceuticals Limited (Trading AS Pressura Neuro) | TRAN, ERIC | 1629 | — | Non-Final OA | 56d | Pending | Mar 07, 2022 |
| 17678295 | Relative Quantitation Using Electrochemical Mass Spectrometry | New Jersey Institute Of Technology | ALABI, OYELEYE A | 1797 | §103 | Non-Final OA | 1d overdue | Pending | Feb 23, 2022 |
| 17421184 | Monitoring Cooking Appliances | Pippa Technologies Limited | PAIK, SANG YEOP | 3761 | §103 | Non-Final OA | 26d | Pending | Jul 07, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial